Actively Recruiting
Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery
Led by Boston Children's Hospital · Updated on 2026-01-07
50
Participants Needed
1
Research Sites
73 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to learn more about blood management in children undergoing heart surgery, such as the right amounts, and the best blood products, to administer. It also aims to develop a mathematical model that may help researchers better predict and treat patients who need blood transfusions during heart surgery.
CONDITIONS
Official Title
Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatric patients under 18 years of age
- Undergoing cardiac surgery with clear prime on cardio-pulmonary bypass at Boston Children's Hospital
You will not qualify if you...
- Known hemolytic disorders
- Receiving nitric oxide before surgery
- Abnormal coagulation on routine preoperative assessment
- Patients on heparin, apixaban, warfarin, or bivalirudin are allowed if held appropriately for elective surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
Research Team
J
Jocelyn Booth, BSN
CONTACT
R
Rachel Bernier, MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here